EA202092030A1 - Офтальмологическая композиция, включающая диквафозол и катионный полимер - Google Patents
Офтальмологическая композиция, включающая диквафозол и катионный полимерInfo
- Publication number
- EA202092030A1 EA202092030A1 EA202092030A EA202092030A EA202092030A1 EA 202092030 A1 EA202092030 A1 EA 202092030A1 EA 202092030 A EA202092030 A EA 202092030A EA 202092030 A EA202092030 A EA 202092030A EA 202092030 A1 EA202092030 A1 EA 202092030A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- cationic
- copolymer
- hydrolyzed
- polymer
- ophthalmic composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7084—Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dispersion Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018035578 | 2018-02-28 | ||
| PCT/JP2019/007542 WO2019168023A1 (ja) | 2018-02-28 | 2019-02-27 | ジクアホソルおよびカチオン性ポリマーを含有する眼科用組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA202092030A1 true EA202092030A1 (ru) | 2020-11-16 |
Family
ID=67806273
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA202092030A EA202092030A1 (ru) | 2018-02-28 | 2019-02-27 | Офтальмологическая композиция, включающая диквафозол и катионный полимер |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20210000844A1 (enExample) |
| EP (1) | EP3760207A4 (enExample) |
| JP (4) | JP6716800B2 (enExample) |
| KR (3) | KR102472773B1 (enExample) |
| CN (2) | CN117137866A (enExample) |
| BR (1) | BR112020017661A2 (enExample) |
| CA (1) | CA3091700A1 (enExample) |
| EA (1) | EA202092030A1 (enExample) |
| MX (2) | MX2020008925A (enExample) |
| PH (1) | PH12020551313B1 (enExample) |
| SG (1) | SG11202007977RA (enExample) |
| TW (3) | TWI833406B (enExample) |
| UA (1) | UA129517C2 (enExample) |
| WO (1) | WO2019168023A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6716800B2 (ja) * | 2018-02-28 | 2020-07-01 | 参天製薬株式会社 | ジクアホソルおよびカチオン性ポリマーを含有する眼科用組成物 |
| JP7526718B2 (ja) * | 2019-02-27 | 2024-08-01 | 参天製薬株式会社 | ジクアホソルまたはその塩、ビニル系高分子およびセルロース系高分子を含有する眼科用組成物 |
| KR102656181B1 (ko) * | 2019-08-27 | 2024-04-08 | 산텐 세이야꾸 가부시키가이샤 | 디쿠아포솔 또는 그 염 및 폴리비닐피롤리돈을 함유하는 수성 안과용 조성물 |
| KR102365008B1 (ko) * | 2020-06-23 | 2022-02-23 | 주식회사태준제약 | 디쿠아포솔을 포함하는 점안 조성물 |
| JP7230169B2 (ja) * | 2020-12-25 | 2023-02-28 | 参天製薬株式会社 | ジクアホソルまたはその塩、銀塩およびイオン性等張化剤を含有する水性点眼液 |
| CN113712910A (zh) * | 2021-08-05 | 2021-11-30 | 广州市桐晖药业有限公司 | 一种滴眼液及其制备方法 |
| KR102794468B1 (ko) | 2022-04-04 | 2025-04-14 | 서울대학교산학협력단 | 감미 억제용 조성물 및 식품의 감미 억제 방법 |
| KR20250038935A (ko) * | 2023-09-13 | 2025-03-20 | 루다큐어 주식회사 | 8-옥소-2'-데옥시구아노신 또는 이의 약학적으로 허용가능한 염을 포함하는 수용액 형태의 점안제 |
| KR20250160050A (ko) | 2024-05-03 | 2025-11-11 | 삼천당제약주식회사 | 물리화학적 특성이 개선된 안구건조증 예방 또는 치료용 약학 조성물 |
| CN119970633A (zh) * | 2025-03-26 | 2025-05-13 | 苏州乐珠制药有限公司 | 一种地夸磷索钠滴眼液及其制备方法 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01294620A (ja) | 1988-05-19 | 1989-11-28 | Kissei Pharmaceut Co Ltd | 水溶液製剤およびその製造方法 |
| US5358706A (en) * | 1992-09-30 | 1994-10-25 | Union Carbide Chemicals & Plastics Technology Corporation | Muco-adhesive polymers |
| US5422116A (en) * | 1994-02-18 | 1995-06-06 | Ciba-Geigy Corporation | Liquid ophthalmic sustained release delivery system |
| JP3155689B2 (ja) * | 1995-08-10 | 2001-04-16 | 昭和薬品化工株式会社 | 消炎点眼剤 |
| US5900407A (en) | 1997-02-06 | 1999-05-04 | Inspire Pharmaceuticals, Inc. | Method of treating dry eye disease with uridine triphosphates and related compounds |
| EP1012154B1 (en) | 1997-07-25 | 2004-03-17 | Inspire Pharmaceuticals, Inc. | Salts of di(uridine 5'-tetraphosphate), method for preparation and uses thereof |
| JP2001294620A (ja) | 2000-04-11 | 2001-10-23 | Showa Denko Kk | プラスチックレンズ材料、該材料の製造方法、プラスチックレンズ用組成物、該組成物を硬化してなるプラスチックレンズ、及び該プラスチックレンズの製造方法 |
| BR0111297A (pt) * | 2000-05-30 | 2004-01-06 | Santen Pharmaceutical Co Ltd | Promotor de migração epitelial corneana |
| KR101484499B1 (ko) * | 2005-02-14 | 2015-01-20 | 존슨 앤드 존슨 비젼 케어, 인코포레이티드 | 안과용 렌즈의 제조방법, 안과용 장치 및 콘택트 렌즈 |
| JP4515960B2 (ja) | 2005-05-19 | 2010-08-04 | 株式会社資生堂 | 整髪料洗浄剤及びその使用方法 |
| KR100870104B1 (ko) * | 2005-11-28 | 2008-11-26 | 주식회사 머젠스 | 안구건조증 치료 및 예방용 조성물 |
| KR20100080798A (ko) * | 2007-10-12 | 2010-07-12 | 레솔빅스 파마슈티칼즈, 인코퍼레이티드 | 안과 질환의 치료를 위한 옥실리핀 화합물 |
| CN101977630B (zh) * | 2008-03-07 | 2012-11-21 | 太阳医药高级研发有限公司 | 眼药组合物 |
| KR20140003493A (ko) * | 2010-12-28 | 2014-01-09 | 산텐 세이야꾸 가부시키가이샤 | 디쿠아포솔 함유 점안액 및 그 제조 방법, 불용성 석출물 발생의 억제 방법 |
| KR20190002751A (ko) * | 2012-03-26 | 2019-01-08 | 산텐 세이야꾸 가부시키가이샤 | 디쿠아포솔 함유 점안액 |
| SG11201608402WA (en) * | 2014-05-07 | 2016-11-29 | Croma Pharma Ges M B H | Aqueous ophthalmic solution and method for treating dry eye syndrome |
| CN106456791B (zh) * | 2014-06-10 | 2021-08-10 | 日本乐敦制药株式会社 | 眼科用水性组合物 |
| KR101867791B1 (ko) * | 2014-12-25 | 2018-06-15 | 산텐 세이야꾸 가부시키가이샤 | 수성 점안액 |
| KR101587385B1 (ko) * | 2015-07-29 | 2016-01-21 | 국제약품공업주식회사 | 사이클로스포린 함유 무자극성의 안약조성물 및 편리한 제조방법 |
| WO2017033967A1 (ja) * | 2015-08-24 | 2017-03-02 | 参天製薬株式会社 | 眼科用フィルム製剤 |
| PT3266446T (pt) * | 2016-07-07 | 2019-01-30 | Salvat Lab Sa | Composição oftálmica compreendendo óleo de rícino e triglicérido de cadeia média |
| CN106772747B (zh) * | 2016-12-26 | 2022-10-18 | 深圳市光科全息技术有限公司 | 一种光学膜及其制作方法 |
| KR102281853B1 (ko) * | 2017-04-25 | 2021-07-23 | 와카모토 세이야꾸 가부시끼가이샤 | 열겔화 인공 누액 |
| JP6582029B2 (ja) * | 2017-10-03 | 2019-09-25 | 株式会社メニコン | 眼科用組成液及びその使用方法 |
| JP6716800B2 (ja) | 2018-02-28 | 2020-07-01 | 参天製薬株式会社 | ジクアホソルおよびカチオン性ポリマーを含有する眼科用組成物 |
| CN108853016A (zh) * | 2018-09-26 | 2018-11-23 | 广州大光制药有限公司 | 一种地夸磷索钠滴眼液及其制备方法 |
| JP7526718B2 (ja) * | 2019-02-27 | 2024-08-01 | 参天製薬株式会社 | ジクアホソルまたはその塩、ビニル系高分子およびセルロース系高分子を含有する眼科用組成物 |
| KR102656181B1 (ko) * | 2019-08-27 | 2024-04-08 | 산텐 세이야꾸 가부시키가이샤 | 디쿠아포솔 또는 그 염 및 폴리비닐피롤리돈을 함유하는 수성 안과용 조성물 |
-
2019
- 2019-02-27 JP JP2020503563A patent/JP6716800B2/ja active Active
- 2019-02-27 SG SG11202007977RA patent/SG11202007977RA/en unknown
- 2019-02-27 KR KR1020207027473A patent/KR102472773B1/ko active Active
- 2019-02-27 CA CA3091700A patent/CA3091700A1/en active Pending
- 2019-02-27 BR BR112020017661-3A patent/BR112020017661A2/pt unknown
- 2019-02-27 MX MX2020008925A patent/MX2020008925A/es unknown
- 2019-02-27 US US16/976,504 patent/US20210000844A1/en not_active Abandoned
- 2019-02-27 CN CN202311151214.4A patent/CN117137866A/zh active Pending
- 2019-02-27 TW TW111140996A patent/TWI833406B/zh active
- 2019-02-27 EP EP19759990.5A patent/EP3760207A4/en active Pending
- 2019-02-27 KR KR1020257011738A patent/KR20250053220A/ko active Pending
- 2019-02-27 EA EA202092030A patent/EA202092030A1/ru unknown
- 2019-02-27 TW TW113102160A patent/TWI898399B/zh active
- 2019-02-27 CN CN201980015357.8A patent/CN111757742B/zh active Active
- 2019-02-27 TW TW108106730A patent/TWI781296B/zh active
- 2019-02-27 KR KR1020227041383A patent/KR102796051B1/ko active Active
- 2019-02-27 UA UAA202006163A patent/UA129517C2/uk unknown
- 2019-02-27 WO PCT/JP2019/007542 patent/WO2019168023A1/ja not_active Ceased
- 2019-02-27 PH PH1/2020/551313A patent/PH12020551313B1/en unknown
-
2020
- 2020-06-10 JP JP2020100953A patent/JP7297718B2/ja active Active
- 2020-08-26 MX MX2022014791A patent/MX2022014791A/es unknown
-
2022
- 2022-07-21 JP JP2022116528A patent/JP7472202B2/ja active Active
-
2024
- 2024-02-13 JP JP2024019332A patent/JP2024045506A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA202092030A1 (ru) | Офтальмологическая композиция, включающая диквафозол и катионный полимер | |
| PE20220256A1 (es) | Sistemas de casx artificiales | |
| ZA202501799B (en) | Recombinant nucleic acids encoding cosmetic protein(s) for aesthetic applications | |
| BR112018072343A2 (pt) | método de determinação de um filtro para uma lente oftálmica em função de uma grandeza representativa de uma sensibilidade dinâmica do olho de um portador a uma variação de um fluxo luminoso | |
| BR112018070323A2 (pt) | vacina contra rsv | |
| BR112019000178A2 (pt) | hidrogéis de silicone compreendendo n-alquil metacrilamidas e lentes de contato produzidas a partir dos mesmos | |
| BR112018006309A2 (pt) | camada implantável que compreende fibras plasticamente deformadas | |
| PE20211469A1 (es) | Proteinas f de prefusion del vrs estabilizadas | |
| BR112019000236A2 (pt) | hidrogéis de silicone compreendendo poliamidas | |
| EA202092718A1 (ru) | Композиции для контроля патогенов и пути их применения | |
| CY1125184T1 (el) | Enωσεις | |
| WO2004004757A8 (en) | Treatment for eye disorder | |
| FR3052977B1 (fr) | Composition comprenant au moins un polymere acrylate et au moins une silicone choisie parmi les silicones fonctionalisees par au moins un groupement mercapto ou thiol | |
| EP3515444A4 (en) | COMPOSITION FOR TREATING EYE DISEASES AND METHOD FOR USE AND PRODUCTION | |
| BR112019006346A2 (pt) | composições cosméticas para os cabelos e métodos para o tratamento dos cabelos e para conferir aos cabelos um ou mais efeitos de cuidado dos cabelos | |
| EA202191212A1 (ru) | Композиции и способы для обработки биопленок без индуцирования резистентности к противомикробным препаратам | |
| MY197057A (en) | Method for producing silicone hydrogel contact lenses | |
| CY1124640T1 (el) | Μια meθοδος αντιμετωπισης μυκητιασικων μολυνσεων | |
| BR112015028726A2 (pt) | sistema e método para programar uma lente oftálmica energizada | |
| EA202192543A1 (ru) | Вектор и способ для лечения синдрома ангельмана | |
| PT3660545T (pt) | Composição de hidrogel de silicone, lente de hidrogel de silicone, e método de fabrico de lente de hidrogel de silicone | |
| BR112015029954A2 (pt) | composição e processo para tratar as fibras queratínicas | |
| MX393880B (es) | Co-cristales de compuestos de glicina sustituida y usos de los mismos. | |
| BR0204921A (pt) | Uso de silicones aminados particulares em pré- ou pós-tratamento de descoloração de fibras queratìnicas e processo de descoloração das mesmas | |
| EP3829489A4 (en) | EYE SURGICAL INJECTOR SYSTEM |